Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020

SELL
$15.08 - $27.04 $180,960 - $324,480
-12,000 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$14.57 - $23.96 $18,066 - $29,710
1,240 Added 11.52%
12,000 $280,000
Q1 2020

Apr 30, 2020

SELL
$10.27 - $21.23 $843,567 - $1.74 Million
-82,139 Reduced 88.42%
10,760 $160,000
Q4 2019

Jan 28, 2020

BUY
$8.36 - $23.81 $776,635 - $2.21 Million
92,899 New
92,899 $1.9 Million
Q3 2019

Nov 04, 2019

SELL
$9.83 - $14.82 $141,375 - $213,141
-14,382 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$12.9 - $20.8 $185,527 - $299,145
14,382 New
14,382 $194,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $723M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.